Russian Space Corporation Factory Denies Chewing Tobacco Allegations

Nov.25.2024
Russian Space Corporation Factory Denies Chewing Tobacco Allegations
A subsidiary factory of the Russian Space Corporation has denied allegations of illegally producing chewing tobacco, accusing the reports of defaming the company. It has requested regulatory authorities to block the dissemination of the related reports.

According to a report by RBC on November 22nd, the "Arsenal" machine-building plant in St. Petersburg, Russia (affiliated with the Russian state space company "Roscosmos"), denied reports of an illegal chewing tobacco production lab within its premises.


According to sources, on November 22, multiple media outlets reported information regarding allegations that the company was involved in the illegal production of chewing tobacco. The reports stated that during a crackdown on illegal immigration operations on November 20, law enforcement officials discovered a laboratory for producing chewing tobacco in a building owned by the company, as well as 55 packages and 10 bags of powdered substances. Additionally, it was reported that inspectors also seized a model hand grenade from an employee.


The factory spokesperson stated that these allegations are unrelated to the company and believes that the related reports are intended to tarnish the company's image and harm its commercial reputation.


Currently, the factory's legal department has submitted a request to the Russian Federal Communications, Information Technology, and Mass Media Supervision Agency (Roskomnadzor) to block the dissemination of this information.


According to reports, Arsenal is an industrial company in Russia, located in the Kirovsky District of St. Petersburg. It was established by Peter the Great in 1711. Today, the main activities of the factory include the production of aerospace and maritime technical equipment.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts Exclusive with ARAC: What Juul’s FDA Approval Reveals About U.S. Tobacco Regulation
2Firsts spoke with the leadership team at ARAC to analyze the regulatory context and industry implications of the FDA’s approval of five Juul products. ARAC noted that the decision highlights FDA’s increasing emphasis on real-world switching behavior as a key criterion for authorization. While more MGOs may follow, companies must meet rigorous standards in toxicology, manufacturing, and population-level risk assessments.
Jul.21
Philippine Vape Industry Observers: Market Entering a “Turbulent Phase” Amid Growing Uncertainty
Philippine Vape Industry Observers: Market Entering a “Turbulent Phase” Amid Growing Uncertainty
Since July, the Philippine NBI has stepped up its vape crackdown, reclassifying illegal sales from commercial to criminal offenses and seizing over PHP 44 million in products. Industry insider Lucas sees this as both a response to the black market and a political power struggle. With legal channels shrinking and illicit trade rising, the vape sector faces unprecedented turmoil.
Jul.10 by 2FIRSTS.ai
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
US FDA Rejects Imperial Tobacco’s blu 2.4% E-Cigarette Application, Citing Failure to Prove Health Benefits Outweigh Risks
The US Food and Drug Administration (FDA) has issued a Marketing Denial Order (MDO) for Imperial Tobacco’s blu® Disposable Classic Tobacco 2.4% e-cigarette, prohibiting its sale and distribution in the United States. FDA’s review found that the company’s Premarket Tobacco Product Application (PMTA) did not provide sufficient evidence to demonstrate that the product could help smokers fully switch to e-cigarettes or significantly reduce cigarette consumption. Instead, existing evidence suggested
Aug.20 by 2FIRSTS.ai
Australia Cracks Down on Illegal Vapes: Melbourne Retail Store Caught with $30,000 Worth of Goods
Australia Cracks Down on Illegal Vapes: Melbourne Retail Store Caught with $30,000 Worth of Goods
Australian authorities have intensified efforts against the illegal vape trade, with the Therapeutic Goods Administration (TGA) and Victoria Police seizing around AUD 40,000 (USD 30,000) worth of illegal e-cigarettes from a well-known retail store in central Melbourne. Additional illegal tobacco and cash were also discovered on-site
Aug.18 by 2FIRSTS.ai
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco’s Greece Subsidiary Posts $900 Million Revenue in 2024, Plans to Boost Ploom Market Expansion
Japan Tobacco International’s (JTI) Greece operations are projected to generate over €800 million (approximately $900 million) in revenue in 2024, with a net profit of €958,000 (about $1.11 million), marking a growth in market share despite challenging conditions. JTI’s innovation is driving market expansion in Greece, with its Ploom products successfully entering the market.
Jul.18 by 2FIRSTS.ai
PMI Launches Global Smoke-Free Travel Information Platform: 2Firsts Shares User Insights and Trend Analysis
PMI Launches Global Smoke-Free Travel Information Platform: 2Firsts Shares User Insights and Trend Analysis
Philip Morris International(PMI) has launched the world’s first smoke-free travel platform to address information gaps and regulatory uncertainties for adult nicotine users. 2Firsts reviews its age verification, journey-focused interface, advanced search, and user support, highlighting how it helps adults make compliant cross-border purchases.
Jul.11 by 2FIRSTS.ai